Product Name | MF | CAS | Details |
---|
Acetamide, N-[(4S,6S)-2-(aminosulfonyl)-5,6-dihydro-6-methyl-7,7-dioxido-4H-thieno[2,3-b]thiopyran-4-yl]- | C10H14N2O5S3 | 147200-03-1 | Details |
1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]- | C19H22ClN5O | 157072-19-0 | Details |
Cilostazol Related Compound C | C31H45N9O2 | 865792-18-3 | Details |
Bisoprolol Impurity B | C18H31NO4 | 1447715-44-7 | Details |
1-(4-((2-hydroxyethoxy)methyl)phenoxy)-3-(isopropylamino)propan-2-ol | C15H25NO4 | 109791-18-6 | Details |
[1,1'-Biphenyl]-2,3-diol | C12H10O2 | 1133-63-7 | Details |
1-Propanaminium, 3-carboxy-N,N,N-trimethyl-2-oxo-, inner salt (9CI, ACI) | C7H13NO3 | 10457-99-5 | Details |
Benzaldehyde, 4,4',4''-nitrilotris- | C21H15NO3 | 119001-43-3 | Details |
2-Propen-1-aminium, 3-carboxy-N,N,Ntrimethyl-, chloride (1:1) | C7H13ClNO2 | 6538-82-5 | Details |
,4-bis(3-chlorophenyl)-piperazine | C16H16Cl2N2 | 79975-63-6 | Details |
1-Butanone, 4-(methylnitrosoamino)-1-(3-pyridinyl)- ( | C10H13N3O2 | 64091-91-4 | Details |
Benzeneacetic acid, 2-(bromomethyl)-α-methyl- | C10H11BrO2 | 2172861-70-8 | Details |
2-nitroso-octahydrocyclopenta[c]pyrrole | C7H12N2O | 54786-86-6 | Details |
Trazodone 4, 4'-dimer | C40H46Cl2N10O2 | 2727463-29-6 | Details |
4H-Thieno[2,3-b]thiopyran-4-ol, 5,6-dihydro-6-methyl-, 7,7-dioxide, (4S,6S)- | C8H10O3S2 | 147086-81-5 | Details |
Ethanone, 1-?(3-?methoxy-?2-?nitrophenyl)?- | C9H9NO4 | 33852-43-6 | Details |
2,5-dibromo-1,4-benzenediamine | C6H6Br2N2 | 25462-61-7 | Details |
Sildenafil impurity A | C23H32N6O4S | 1391053-95-4 | Details |
1,3-Benzenedimethan-a1,a1,a3-d3-ol, a3-[[(1,1- dimethylethyl)amino]methyl]-6-hydroxy- | C13H21NO3 | 1219798-60-3 | Details |
1-[4-(Acetyloxy)-3-[(acetyloxy)methyl]phenyl]-2-chloroethanone | C13H21NO3 | Details |
Bisoprolol EP impurity D | C26H40N2O5 | 1225195-71-0 | Details |
Ornidazole Impurity 5 | C7H9N3O3 | 16773-51-6 | Details |
Indometacin Impurity D | Details |
1,2,4-Triazolo[4,3-a ]pyridinium, 1-[3-[4-(3-chlorophenyl)-1-pipera zinyl]propyl]-3-oxo- | C19H23ClN5O | 157072-18-9 | Details |
Bisoprolol Impurity C | C25H38N2O4 | 1225195-70-9 | Details |
1-chloro-3-[4-[[2-(1-methylethoxy)ethoxy]methyl] phenoxy]-2-Propanol, | C15H23ClO4 | 704200-67-9 | Details |
Dobutamine Impurity 18 | Details |
4,4′-[oxybis(methylene)]bis-Phenol | C14H14O3 | 76890-93-2 | Details |
4-amino-1-methyl-1H -Imidazole-5-carboxylic acid ethyl ester | C7H11N3O2 | 61982-18-1 | Details |
(3S )- 3-amino-2-Piperidinone hydrochloride | C5H11ClN2O | 42538-31-8 | Details |
Pyrancoumarin | C20H18O4 | 518-20-7 | Details |
D-DESTHIOBIOTIN | C10H18N2O3 | 533-48-2 | Details |
Aripiprazole Impurity G | C48H56Cl4N6O4 | 1797986-18-5 | Details |
(2S,5S)-5-BENZYL-3,6-DIOXO-2-PIPERAZINEACETIC ACID | C13H14N2O4 | 5262-10-2 | Details |
(R)-Pomalidomide | C13H11N3O4 | 202271-90-7 | Details |
2-Naphthalenecarboxylic acid, 6-bromo- | C11H7BrO2 | 5773-80-8 | Details |
Benzene, 1,4-diethenyl- | C10H10 | 105-06-6 | Details |
Acemetacin Impurity C | Details |
Dobutamine Impurity 5 | C20H27NO3 | 334947-72-7 | Details |
1-(3-chlorophenyl)-4-(3-isopropoxypropyl)piperazine hydrochloride | Details |
3-hydroxy-4-methoxy-α-[(methylamino)methyl]-benzenemethanol | C10H15NO3 | 29866-04-4 | Details |
ARIPIPRAZOLE Impurity 16 | C26H32N2O5 | 1424858-02-5 | Details |
(2R)-4-amino-2-hydroxy-N,N,N-trimethyl-4-oxobutan-1-aminium (carnitinamide), | C7H17ClN2O2 | 6490-20-6 | Details |
4-amino-3-chloro-N-(5,6-dimethoxypyrimidin-4-yl)benzenesulfonamide | C12H13ClN4O4S | Details |
Phenol, 2,4-bis[1-(4-hydroxyphenyl)-1-methylethyl]- | C24H26O3 | 2300-15-4 | Details |
Trazodone Impurity G hydrochloride | 2470441-00-8 | Details |
1-(3-(3-(3-chlorophenyl)propoxy)propyl)piperidine | Details |
4'-hydroxytrazodone | C19H22ClN5O2 | 53818-10-3 | Details |
1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-[3-[4- (3-chlorophenyl)-1-oxido-1-piperazinyl]propyl]- | C19H22ClN5O2 | 55290-68-1 | Details |
Ractopamine-D6 | C18H24ClNO3 | 1185177-97-2 | Details |
1-Piperazinecarboxylic acid, 2-(trifluoromethyl)-, 1,1-dimethylethyl ester (9CI, ACI) | C10H17F3N2O2 | 886779-77-7 | Details |
Bisoprolol EP Impurity F | C18H31NO4 | 1798418-82-2 | Details |
1-(3-(chloromethyl)-4-hydroxyphenyl)ethanone | C9H9ClO2 | 24085-05-0 | Details |
Ractopamine-D3 | C18H23NO3 | 1219908-63-0 | Details |
4(1H )-Pyrimidinone, 6-chloro-5-methoxy- | C5H5ClN2O2 | 1224097-08-8 | Details |
Benzenemethanol, 4-hydroxy-3-methoxy-α-[(methylamino)methyl]- , hydrochloride (1:1) (ACI) | C10H16ClNO3 | 881-95-8 | Details |
Bisoprolol Impurity A | C13H21NO3 | 62572-93-4 | Details |
(S)-Pomalidomide | C13H11N3O4 | 202271-89-4 | Details |
Dobutamine Impurity 4 | C20H27NO3 | 140165-60-2 | Details |
methyl 4-chloro-5-methoxyquinoline-6-carboxylate | Details |
1-[3-(3-phenylpropoxy)propyl]-Piperidine | C17H27NO | 362665-54-1 | Details |
4-AMINO-N-(6-CHLORO-5-METHOXY-4-PYRIMIDINYL)BENZENESULFONAMIDE | C11H11ClN4O3S | 5018-23-5 | Details |
Benzenemethanol, a-[(1S)-1-amino-2-fluoroethyl]-4-(methylsulfonyl)-, (aR)- | C10H14FNO3S | 76639-93-5 | Details |
1-(3-(3-(3-(4-chlorophenyl)propoxy)propoxy)propyl)piperidine | Details |
1-(3-chlorophenyl)-4-(3-isopropoxypropyl)piperazine | Details |
Pitolisant oxide | Details |
1H -Imidazole-4-carboxamide, N -methyl-5-(methylamino)- | C6H10N4O | 6736-40-9 | Details |
DOBUTAMINE EP Impurity C | C21H29NO3 | 61413-44-3 | Details |
Trazodone impurity | C19H22ClN5O | Details |
Benzenemethanol, a-(aminomethyl)-4-hydroxy-3-methoxy-, hydrochloride (1:1) | C9H13NO3.ClH | 1011-74-1 | Details |
[1,1'-Biphenyl]-2,2'-dicarboxylic acid | C14H10O4 | 482-05-3 | Details |
1H -Purine-2,6-dione, 3,7-dihydro-1,7-dimethyl- | C7H8N4O2 | 611-59-6 | Details |
Adapalene | C28H28O3 | 106685-40-9 | Details |
2,2'-dihydroxy-5,5'-diacetyldiaminebiphenyl | C16H16N2O4 | 98966-14-4 | Details |
4-amino-N-(6-(dimethylamino)-5-methoxypyrimidin-4-yl)benzenesulfonamide | 7749-17-9 | Details |
1-(3-(3-(2-chlorophenyl)propoxy)propyl)piperidine | Details |
10H-Phenothiazine-10-propanamine, 2-chloro-N,N-di(methyl-d3)- | C17H20Cl2N2S | 1228182-46-4 | Details |
1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-[3-(4-phenyl-1-piperazinyl)propyl]- | C19H23N5O | 62337-66-0 | Details |
Indometacin Impurity E | C19H16ClNO4 | 807614-94-4 | Details |
Dorzolamide Hydrochloride | C10H16N2O4S3.ClH | 130693-82-2 | Details |
Pentoxifylline EP Impurity I | C14H14N4O2 | 55247-90-0 | Details |
2-[3-[4-(3-chloro-4-ethylphenyl)piperazin-1-yl]propyl]-[1,2,4]triazolo[4,3-a]pyridin-3-one | C21H26ClN5O | 1346599-35-6 | Details |
Piperazine, 1-(3-chlorophenyl)-4-[3-(2-methylpropoxy)propyl]- | C17H27ClN2O | 2470436-00-9 | Details |
2-(4-ethylbenzyl)cyclopentanone | C14H18O | 639857-67-3 | Details |
N-(6-chloro-5-methoxypyrimidin-4-yl)-4-(6-chloro-5-methoxypyrimidin-4-ylamino)benzenesulfonamide | C6H9N3O2 | 36315-01-2 | Details |
1-Piperazinepropanol, 4-(3-chlorophenyl)- | C13H19ClN2O | 32229-98-4 | Details |
2-Buten-1-aminium, 4-amino-N ,N ,N -trimethyl-4-oxo- | C7H15N2O+ | 857162-57-3 | Details |
Diclofenac Impurity D | C14H11BrClNO2 | 127792-23-8 | Details |
Benzaldehyde, 4-ethenyl- | C9H8O | 1791-26-0 | Details |
2,2′-(methylimino)bis[1-(3,4-dihydroxyphenyl)-ethanone | C17H17NO6 | 1188265-23-7 | Details |
Acemetacin Impurity E | C25H26ClNO6 | 75302-98-6 | Details |
Phenol, 2-amino-4-bromo- | C6H6BrNO | 40925-68-6 | Details |
Piperazine, 1,1′-(1,3-propanediyl)bis[4-(3-chlorophenyl)- | C23H30Cl2N4 | 6323-09-7 | Details |
2-Propen-1-one, 1-(4-ethylphenyl)-2-methyl- | C12H14O | 70639-76-8 | Details |
Indometacin | C19H15Cl2NO4 | 402849-26-7 | Details |
1-Piperazinebutanol, 4-(2,3-dichlorophenyl)-, hydrochloride (1:1) | C14H21Cl3N2O | 1797132-04-7 | Details |
5-HYDROXY-2[5H]-FURANONE | C4H4O3 | 14032-66-7 | Details |
1,2,4-Triazolo[4,3-a]pyridin-3(2H)-one, 2-[3-[4-(3-bromophenyl)-1-piperazinyl]propyl]- | C19H22BrN5O | 1263358-13-9 | Details |
Dobutamine impurity 20 | C20H27NO3 | 334947-73-8 | Details |
1,2,4-Triazolo[4,3-a ]pyridin-3(2H )-one, 2-[3-[4-(3,4-dichlorophenyl)- 1-piperazinyl]propyl]- | C19H21Cl2N5O | 1263358-12-8 | Details |
Product Total: Product Page: | ||||
1 2 |